EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt’s lymphoma cells. Evidence for a critical role for ICAM-2
Rajiv Khanna(QIMR Berghofer Medical Research Institute), Denis J. Moss(The University of Queensland), Scott R. Burrows(Australian National University), T B Sculley(QIMR Berghofer Medical Research Institute), Catherine Jacob(QIMR Berghofer Medical Research Institute), H Griffin(University of Birmingham), I S Misko(QIMR Berghofer Medical Research Institute), Martin Rowe(University of Wales), A. B. Rickinson(QIMR Berghofer Medical Research Institute), Andreas Suhrbier(The University of Queensland)
Cited by 31
Related Papers
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
|Proceedings of the National Academy of Sciences|1999|332
A Structural Basis for the Selection of Dominant αβ T Cell Receptors in Antiviral Immunity
|Immunity|2003|323
Estimating the global burden of Epstein–Barr virus-related cancers
|Journal of Cancer Research and Clinical Oncology|2021|313